Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
2.630
+0.090 (3.54%)
Oct 5, 2026, 10:21 AM EDT - Market open
PACB Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 159.27 | 160.01 | 154.01 | 200.52 | 128.3 | 130.51 |
Revenue Growth | 2.02% | 3.89% | -23.19% | 56.29% | -1.69% | 65.43% |
Gross Profit Gross Profit Growth | 46.86 | 54.85 | 47.67 | 58.2 | 53.47 | 59.17 |
Operating Income Operating Income Growth | -177.54 | -551.66 | -290.66 | -310.37 | -304.82 | -178.16 |
Net Income Net Income Growth | -131.39 | -546.38 | -309.85 | -306.74 | -314.25 | -181.22 |
Earnings Per Share EPS Growth | -0.43 | -1.82 | -1.13 | -1.21 | -1.40 | -0.89 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Europe, Middle East and Africa Europe, Middle East and Africa Growth | 50.54 | 44.05 | 34.59 | 40.66 | 22.6 | 30.27 |
Asia Pacific Asia Pacific Growth | 35.62 | 43.16 | 40.71 | 54.45 | 36.15 | 35.72 |
United States of America United States of America Growth | - | 69.7 | 75.3 | 100.5 | 66.8 | - |
Americas (excl. United States) Americas (excl. United States) Growth | - | 3.1 | 3.41 | 4.91 | 2.76 | - |
Total Total Growth | 159.27 | 160.01 | 154.01 | 200.52 | 128.3 | 130.51 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 236.87 | 279.51 | 389.93 | 631.42 | 772.32 | 1,044 |
Total Debt Total Debt Growth | 709.13 | 702.42 | 672.43 | 933.93 | 948.48 | 955.36 |
Net Cash (Debt) Net Cash Growth | -472.25 | -422.92 | -282.5 | -302.51 | -176.16 | 89.05 |
Net Cash Growth | - | - | - | - | - | -67.83% |
Net Cash Per Share Net Cash Per Share Growth | -1.55 | -1.41 | -1.03 | -1.19 | -0.78 | 0.44 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -118.05 | -111.21 | -206.06 | -259.17 | -263.21 | -111.18 |
Capital Expenditures CapEx Growth | -5.37 | -2.71 | -6.19 | -8.84 | -16.75 | -5.93 |
Free Cash Flow Free Cash Flow Growth | -123.42 | -113.92 | -212.25 | -268.02 | -279.96 | -117.11 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.42% | 34.28% | 30.95% | 29.02% | 41.68% | 45.33% |
Operating Margin | -111.47% | -344.78% | -188.73% | -154.78% | -237.58% | -136.51% |
Pretax Margin | -81.97% | -341.28% | -200.98% | -158.67% | -244.92% | -210.61% |
Profit Margin | -82.49% | -341.47% | -201.18% | -152.97% | -244.93% | -138.85% |
FCF Margin | -77.49% | -71.20% | -137.81% | -133.66% | -218.20% | -89.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 4.96 | 3.53 | 3.50 | 13.08 | 14.42 | 34.58 |